A 1-hour sample-to-answer, molecular device successfully detected common causative pathogens of acute febrile illness with high positive and negative percent agreement directly in whole blood, ...
> Canada's LifeLabs Medical Laboratory Services has agreed to buy diagnostics provider CML Healthcare for about $1.2 billion. Article > BioFire Diagnostics won FDA clearance for its FilmArray Blood ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, announces that BioFire Diagnostics, its molecular biology ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
Houston, TX – Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health. Researchers at bioMérieux Inc. conducted a retrospective ...
Candida auris, an emerging fungal pathogen resistant to many antimicrobial agents, continues to threaten U.S. public health. Researchers at bioMérieux Inc. conducted a retrospective analysis of blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback